Expanded genetic testing and early transplant referrals anchor new myelofibrosis care recommendations
The American Society of Hematology (ASH) has released guidelines on the management of myelofibrosis, a rare and life-threatening blood cancer. The new guidelines recommend expanded molecular testing, early transplant referral, appropriate use of JAK inhibitors and aspirin therapy in select patients.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
How food allergy risk changes as children grow
-
Asthma drug improves motor function and strength in children with rare muscle diseases in small trial
-
Cornetos nasais: para que servem, anatomia (e hipertrofia dos cornetos)
-
The 10 Best Men's Robes in 2026, Tested by Style Editors
-
Naval research tracks high copper resistance in marine bacteria
-
Quantos litros de água beber por dia? (com calculadora online)
-
The Best Thing You Can Do for Your Brain This Week Might Actually Help Someone Else
-
Experts Say Weight Lifting Is The Fountain Of Youth. Here's How To Get Started At Any Age